ABSTRACT. We examined the structure of the rat kinin B 2 receptor gene (KB 2 r) and encoding messenger RNA (mRNA) processing. Differently from the closely related mouse and rabbit genes that have three exons and two introns, the rat gene purportedly consists of four exons and three introns. There are two purported gene products; one of them contains an upstream ~180-bp open reading frame region ("exon-X") potentially expressed as a result of alternative processing. To examine the processing of rat KB 2 r mRNA, cDNA amplicons were generated using primer pairs directed towards 5' or 3' exon or intron flanking regions. Analyses of intron/exon primary cDNA amplicons showed that introns 1 to 3 are removed sequentially and that "exon-X" removal follows that of intron-3. No evidence was found for "exon-X" expression in polyadenylated (mature) mRNA of adult Wistar, Wistar Kyoto, spontaneously hypertensive or Sprague-Dawley rat tissues. Nor was "exon-X" detected in tissues subject to inflammatory stimulus expressing B 1 kinin receptor mRNA or in 1-to 21-day-old rat embryos or fetuses. The lack of evidence for the expression of "exon-X" in mature mRNA indicates 216 ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 9 (1): 215-230 (2010) C.E. França et al. that the structure of the rat gene is similar to that of the mouse, rabbit and human genes, all consisting of three exons and two introns. The "exon-X" fragment may result from interstitial gene duplication, be a fragment of the ancestral gene, or most likely heterologous transposon insertion of an exonlike fragment into intron-2 of the KB 2 r gene.
INTRODUCTION
Bradykinin, a potent neuropeptide and a vasoactive peptide, has a wide spectrum of biological activities (Couture and Lindsey, 2000; Leeb-Lundberg et al., 2005) . Under physiological conditions, kinin activity is mediated by the interaction of the B 2 kinin receptors (LeebLundberg et al., 2005) . These are present in organ and arterial smooth muscle cells and in rat and human brain nuclei, such as the paratrigeminal nucleus and the nucleus of the solitary tract (Lindsey et al., 1997; de Souza Buck et al., 2002) . Stimulation of arterial B 2 kinin receptors causes resistance vessel vasodilatation and hypotension (Sharma, 2006) . On the other hand, stimulation of central kinin receptors leads to blood pressure increases (Lindsey et al., 1997) , mediated by central sympathetic mechanisms (Caous et al., 2004) . Thus, among other important functions, such as blood pressure regulation, kinins are characterized as mediators of pain and inflammatory responses, both in the central and in the peripheral nervous systems (LeebLundberg et al., 2005) ; they are also important mediators in the cascade of the febrile response (Pessini et al., 2006) . Additionally, bradykinin apparently plays a role in the rat reproductive tissues via the kinin B 2 receptor (Holland et al., 2001) . As vascular agents, they promote vascular permeability and vasodilatation (Leeb-Lundberg et al., 2005) , which are important mechanisms related to the anti-hypertensive action of kinase II inhibitors (Lindsey et al., 1987) .
Two receptor types, both of the protein G receptor family, are known to mediate kinin effects in different tissues throughout the body (Leeb-Lundberg et al., 2005) . The B 1 receptor, normally not present in healthy tissues, has its expression promoted by inflammatory responses caused by injury, infection, or endogenous and exogenous pyrogens (Lungu et al., 2007) . The transcription nuclear factor κB is involved in inducible expression of the human and rat B 1 receptor gene (Ni et al., 1998; Medeiros et al., 2004) . On the other hand, the B 2 kinin receptor is constitutively expressed in most body tissues and is commonly involved in most of the biological activity of kinins in healthy tissues (Leeb-Lundberg et al., 2005) .
In the rat, the coding sequence of B 2 kinin receptors, deduced from cDNA (McEachern et al., 1991) , and the cloning and sequencing of the gene (Pesquero et al., 1994; Wang et al., 1994) accompanied molecular characterization of the human (Eggerickx et al., 1992; Powell et al., 1993; Park et al., 1994; Ma et al., 1994a; Kammerer et al., 1995) , murine (McIntyre et al., 1993; Ma et al., 1994b) , guinea pig (Farmer et al., 1998) , rabbit (Bachvarov et al., 1995) , dog (Hess et al., 2001) , chicken (Schroeder et al., 1997) , frog (Suzuki et al., 2007) , and zebrafish (Bromée et al., 2005) B 2 receptor gene. The B 1 receptor gene has also been cloned and sequenced from humans (Bachvarov et al., 1996) , rabbits (MacNeil et al., 1995) , mice (McIntyre et al., 1993) and rats (Ni et al., 1998; Jones et al., 1999) . Genomic Southern blot analysis of human, rabbit and rat genomes revealed that a single-copy gene encodes the kinin B 2 receptor (Kammerer et al., 1995; Bachvarov et al., 1995) . This also holds true for the human B 1 receptor (Bachvarov et al., 1996) . Structure, product processing and expression of rat KB 2 r Several reports indicate that the gene of these two receptors contains three exons separated by two introns and an intronless coding region located on the third exon (McIntyre et al., 1993; Ma et al., 1994a,b; Wang et al., 1994; Bachvarov et al., 1995) . However, Pesquero et al. (1994) , based on the findings of others (McEachern et al., 1991) , included an "extra" exon in the gene, predicting a four exon-three intron gene structure for the rat (Ratus norvegicus) kinin B 2 receptor gene. Alternative splicing of B 2 receptor mRNA would result in rat "exon-3", herein named "exon-X". This exon, not predicted for mice or for the human kinin B 2 receptor gene, was suggested based on evidence from amplification of reverse-transcriptase products from total RNA (Pesquero et al., 1994) . Results obtained with domain-specific anti-peptide antibodies, amino acid sequence analysis and in vitro transcription and translation suggested a first translation initiation codon in the human and rat "exon-X" (AbdAlla et al., 1996) rather than in exon-4, as previously thought. This would imply a four-exon structure for the rat and human kinin B 2 receptor gene. Translation of gene products initiating either in rat or human exon-3 or exon-4 would putatively lead to expression of B 2 receptor subtypes. However, translation products containing the extended N-terminus have never been reported in rats or humans (Couture and Lindsey, 2000) .
Alternative processing has been suggested for a number of receptor proteins, including rat kinin B 1 (Ni et al., 1998) , the NK1 tachykinin (substance P) receptor (Page, 2006) , the endothelin B receptor (Suzuki et al., 2004) and the glutamate-receptor-coupled ion channel (Kumar et al., 2009) . However, experimental evidence shows that the single type of mature, polyadenylated mRNA does not contain the proposed "exon-X". Furthermore, given that the rat B 2 gene is highly related to the mouse and guinea pig genes, a different gene structure and alternative processing of the rat B 2 receptor mRNA is unlikely.
For a better understanding of the processing of rat kinin B 2 receptor gene products and to gain insight concerning gene structure, we analyzed mature and immature RNA transcripts in adult hypertensive and normotensive rat strains, rat embryos and fetuses, as well as in animals expressing the B 1 kinin receptor induced by pyrogen treatment. The 211 bp of the purported "exon-X" kinin B 2 gene and predicted protein sequences were respectively compared to available data base sequences for a clearer understanding of the structure of this particular gene as to further our knowledge on gene structure and evolution.
MATERIAL AND METHODS

Tissue specimens
Tissues were collected from five adult (three months old) Wistar, Wistar Kyoto, spontaneously hypertensive rats (SHR; Okamoto et al., 1964) , and Sprague-Dawley male and female rats. Under CO 2 anesthesia, animals were quickly dissected for removing the aorta, mesenteric arteries, liver, uterus, lungs, ovaries, hypothalamus, lower brainstem, solitary tract, and paratrigeminal nuclei. Approximately 50 mg of each tissue sample was rapidly frozen in liquid nitrogen and then stored in phenol solution (Trizol, Invitrogen Corporation, Carlsbad, CA, USA) at -80°C for not over 24 h before processing.
Embryo collection
Five female Wistar rats per group were treated with 150 IU/kg pregnant mare serum gonadotropin (Sigma Chemical Company, St. Louis, MO, USA) and after 46 h with 75 IU/ kg human chorionic gonadotropin (Sigma Chemical Company) to provoke super ovulation. Animals were mated and 24 h later vaginal smears were collected for pregnancy verification. From days 1 to 5, 50 embryos were collected from oviducts of 10 rats with 80 μL hyaluronidase (Sigma Chemical Company) to detach embryo cells from granulosa cells; the embryos were washed with M2 and stored in M16 medium (Sigma Chemical Company) and stored in phenol solution at -80°C. Six-to 21-day fetuses were directly collected from the rat uterus, chopped into small pieces, homogenized in a phenol solution, rapidly frozen in liquid nitrogen and stored at -80°C.
LPS treatment
Sixteen animals were injected intraperitoneally with the vehicle alone or 50 μg/kg Escherichia coli bacterial endotoxin lipopolysaccharide (LPS, Sigma Chemical Company) 4 h before sacrifice. Body temperature was monitored every 15 min to determine if there was a febrile response.
RNA extraction
Embryos or 50 mg samples of tissues or fetus were homogenized in 1, 2 or 3 mL phenol. Following addition of chloroform, total RNA was precipitated from the aqueous phase with isopropanol and washed with 75% ethanol.
Reverse transcriptase and amplification reactions
Five-microliter aliquots of total RNA, suspended in RNAse-free water, were submitted to reverse transcriptase (Mulv, Invitrogen Corporation) and c-DNA amplification (ThermoScript RT-PCR system, Invitrogen Corporation) with oligo dT primers for mature mRNA or with random primers for primary mRNA. c-DNA amplification was carried out with selective primers directed towards regions close to the intron/exon boundaries. Amplification products were revealed on 1.5% agarose gels (Gibco, New York, USA). Selected samples were reamplified and the reaction products examined on silver-stained 12.5% polyacrylamide gels (PhastSystem, Pharmacia Biotech, Uppsala, Sweden) and stained with ethidium bromide (United Biochemical Corp., Cleveland, OH, USA). Uterine samples were cycle-sequenced using an Alf automatic sequencer (Pharmacia Biotech).
Statistical analysis
All data are reported as means ± SEM and were analyzed by ANOVA followed by the Student t-test for unpaired analysis. Results with P < 0.001 were considered to be significant.
RESULTS
Processing of the kinin B 2 receptor gene
In order to investigate the sequence of intron removal, primary mRNA cDNA was amplified with primers directed to 3' boundaries of introns 1, 2, or 3 and to the 3' regions of the downstream exons. Table 1 shows the primer location on the kinin B 1 and B 2 receptors as well as on the reference β-actin protein-encoding genes; it also shows the expected size of the respective amplification products.
Contrary to exon/exon primer pairs that generated multiple fragments, each intron/exon primer pair produced only one amplification product. Thus, intron-1, -2 and -3/exon-3 primer pairs generated 0.17-, 1.1-and 3-kb fragments, respectively, each containing all downstream introns and exons of the gene ( Figure 1A ). This may be taken as unequivocal evidence that introns 1, 2 and 3 are removed in sequential order. Similarly, the intron-2/exon-3 primer pair produced a 1.2-kb fragment containing "exon-X", intron-3 and the 5' region of exon-3 ( Figure 1A ).
On the other hand, amplification of primary mRNA with primers directed towards 5' regions of exons and 3' regions of downstream exons produced multiple fragments, corresponding to the different stages of mRNA processing. The exon-1/exon-3 primer pair produced four fragments: a 702-bp product containing exon-2 and the 3' and 5' areas of exons 1 and 3; a 913-bp fragment containing exon-2 and exon-X; a 1.1-kb fragment containing exon-2, exon-X and intron-3, and a 3-kb product containing, in addition to the latter, 1.8 kb of intron-2. The ~26-kb fragment containing the ~23-kb sequence of intron-1, if amplified to any extent, would be unresolvable on high-density gels.
The exon-2/exon-3 primer pair produced four products, with sizes of 0.17, 0.38, 1.3, and 3.1 kb, all homologous to the fragments described above. The exon-X/exon-3 primer pair generated two products sized 0.23 and ~1.1 kb, one of which contained the 0.8-kb sequence of intron-3, making "exon-X" the last fragment to be removed (Table 1, Figure 1 ). To the left, agarose gels showing exon-1/exon-3, exon-2/exon-3 and "exon-X"/exon-3 primary mRNA amplicons. The top right gel shows primary mRNA amplicons of intron-1/exon-2 and intron-2/ "exon-X" primer pairs. At the bottom right, the mature mRNA amplification products of exon/exon primer pairs. B. Representation of the processing of the kinin B 2 gene, deduced from the analyses of exon/exon and intron/exon amplification products shown in A. Note the sequential removal of introns 1, 2, and 3, followed by that of "exon-X", representing a three-exon gene structure in the form of mature mRNA genomic transcripts. M = molecular weight marker; L = liver; H = hypothalamus; U = uterus; Cap = 5´capping of primary mRNA; Poly-A tail = polyadenylation of 3' mature mRNA.
Exon composition of kinin B 2 receptor-encoding mature mRNA
The amplification of reverse transcribed cDNA from polyadenylated mRNA (RT/ Structure, product processing and expression of rat KB 2 r PCR) generated only one gene product, independent of the primer pair, with the exception of the primer pairs with one constituent directed towards exon-X. Thus, the exon-1/exon-3 pair produced a 702-kb fragment and the exon-2/exon-3 primer pair produced a 170-kb product.
Amplification of mature, polyadenylated mRNA of brain and visceral tissues, such as paratrigeminal nuclei, nuclei of the solitary tract, uterus, ovaries, stomach, liver, kidneys, and lungs of Sprague-Dawley, Wistar and Wistar Kyoto rat strains, with exon-1/exon-3 primer pairs only produced the 702-bp fragment containing 5' exon-1, exon-2 and 3' exon-3. The same held true for the amplification of mature mRNA from SHR (data not shown). Ten-microliter aliquots uterus amplification reactions were re-amplified and resolved on silver-stained 12.5% polyacrylamide gels. In spite of the high sensitivity of the procedures, no trace of the 211-bp exon was detected. The "exon-X"/exon-3 pair failed to amplify the B 2 kinin receptor mature mRNA in any of the tissues (Figure 1) .
Cycle sequencing of primary and mature mRNA cDNA transcripts only identified the "exon-X" 211-bp nucleotide sequence in the primary mRNA transcripts (Figure 2 ). Genomic sequence showing contiguous exon-2 3' and exon-3 5' regions (displayed in grey boxes) obtained by cycle-sequencing ripe kinin B 2 receptor-encoding mRNA. In the white box, the genomic sequence of the 211-bp "exon-X" is interposed between exons 2 and 3. The latter was obtained by sequencing the 913-bp primary mRNA amplicon produced by the same exon-2/exon-3 primer pair used for immature mRNA amplification.
Exon composition in pyrogen-treated rats
Mature mRNA was also examined in rats treated with an exogenous pyrogen, a bacterial LPS. Fifty micrograms LPS administered directly into the rat peritoneum produced fever and expression of B 1 kinin receptor mRNA, without altering the expression of the kinin B 2 receptor or the β-actin protein mRNA ( Figure 3A) . The exon-1/exon-3 primer pair yielded only one 702-bp product, both in naive and LPS-treated animals. Figure 3B shows the expression levels of B 1 and B 2 mature receptor mRNA in the different tissues of the Wistar rat. 
B 2 kinin receptor expression during ontogenetic development
Primary and mature mRNA was obtained from rat embryonic and fetal tissues at 1 to 21 gestational days. cDNA amplification showed that the 0.6-kb product of the β-actin protein and the 702-bp product of the B 2 kinin receptor were expressed in embryonic cells from day 1 through 21, both from primary and mature mRNA. In primary RNA, the 913-bp product containing "exon-X" was apparent from day 5 onwards. The 702-bp fragment (not containing "exon-X") was the only amplification product of the exon-1/exon-3 primer pair from mature mRNA cDNA ( Figure 4A ). Reamplification of 10-mL samples of the PCR amplification reactions, resolved on silver-stained polyacrylamide gels, failed to identify the 913-bp product containing the 211-bp sequence. Expression of the 702-bp fragment increased relative to that of the reference β-actin protein from gestational days 8 to 14 ( Figure 4B ). 
Data base matching of gene products and predicted proteins
The rat "exon-X" 211-bp sequence does not share any homology with the recently described kinin B 2 receptor gene sequence predicted from the rat mature mRNA (Genbank, Rattus norvegicus accession number NM_173100.1), horse (Equus caballus, XM_001489272.1), domestic cow (Bos taurus, XM_583508.3), mouse (Mus musculus, NM_009747.2), rabbit (Oryctolagus cuniculus, U33334 ), guinea pig (Cavia porcelus, AJ003243.1), dog (Canis lupus familiaris, NM_001003095.1), human (Homo sapiens, NM_000623), chicken (Gallus gallus, NM_001031553.1), and frog (Xenopus tropicalis, BC155000.1). "Exon-X" displayed full homology to the kinin B 2 receptor genes de-scribed by McEachern et al. (1991) and Pesquero et al. (1994) (a P25023). However, when compared to the entire rat or mouse kinin B 2 receptor gene sequences, significant homology of exon-X was found with intron regions (Table 2 ). Within the 211-bp sequence from Srague-Dawley or Wistar rat, 210 bp showed 96% homology to the 46554-46770 region of the Rattus norvegicus genome (NW_047762.2) and 172 bp showed 76% homology to the Mus musculus genome (31444-31669, NT_166318.1). In both cases, the alignments occurred in intron regions between exons 2 and 3 of the respective kinin B 2 receptor genes. On the other hand, 18 bases of the rat "exon-X" 211-bp sequence showed 90% homology alignment to the exon-3, 3' untranslated region (UTR, 47101-47120), of the Homo sapiens kinin B 2 receptor gene (NT_026437.12).
Mouse exon-1 displayed 84% homology to 96 bases of rat exon-1, while the human gene showed 100% homology to 12 bases of the 111-bp rat exon-1. Eighty-two bases of the 104-bp rat exon-2 showed 83% homology to the mouse gene, while 30 bases of the same exon displayed 81% homology with the human gene exon-2. We also found that 1.35 kb of the rat 3' UTR (exon-3) had 82% homology to the mouse 3' UTR, while 39 bases of the latter displayed 82% homology to human kinin B 2 receptor gene 3' UTR. However, a 662-bp segment of the rat 3'UTR aligned to the mouse gene region, immediately following the 3' open-reading frame (ORF), while a contiguous 685 segment aligned 988 bp downstream ( Table 2) .
The rat exon-3 ORF showed high compatibility to the mouse (92%) and human (83%) kinin B 2 receptor encoding sequences. As in the rat, the mouse and human ORFs have a continuous 1.1-kb sequence, all in 5'exon-3 ( Figure 5B ). However, when the rat ORF was aligned to mouse or human kinin B 2 receptor gene sequences predicted from mRNA (GenBank NM_009747.2 and NM_000623, respectively), ~70 bp of the 3' region showed homology to mouse and human exon-2, revealing an error in the deduced gene structures. Reference gene (Rattus norvegicus) segment to align with species genome-derived kinin B2 receptor genes. The numbers in parentheses represent homology of the respective alignments.
b Regions of species kinin B2 receptor genes to which the reference gene aligned to. ORF = open-reading frame; UTR = untranslated region. The predicted N-terminal ~27 residue related to the 211-bp rat kinin B 2 receptor gene "exon-X" did not match published amino acid sequences (Genbank, accession number P25023). Curiously, the predicted alternative N-terminus of human, rat and mouse proteins (AbdAlla et al., 1996) displayed negligible homology with each other. Figure 5A shows the rat kinin B 2 receptor gene structure and Figure 5B shows the respective encoding mature mRNA and exon alignments to the mouse and human genome.
DISCUSSION
We describe new details of the processing of the B 2 kinin receptor-encoding mRNA; the introns are sequentially removed, since amplification of cDNA from primary mRNA with intron/exon primer pairs produced only one product containing all downstream introns and exons. During processing, "exon-X" is the last fragment to be removed. This occurs after removal of intron-3, suggesting that "exon-X" may have been incorporated to intron-2 of murines or phylogenetic ancestrals. Notwithstanding the evolutionary significance of this fragment, our finding that the 211 bp is not present in mature mRNA led us to conclude that the rat B 2 receptor gene structure is similar to that of mice, humans, and probably other mammalian species ( Figure 5 ). Moreover, this interpretation of the rat gene coincides with a recently published consensus sequence of the N-terminus rat kinin B 2 receptor gene (Genbank accession No. NM_173100). In the latter sequence, deduced from the murine and human kinin B 2 receptor published by McIntyre et al. (1993) , in which the 211-bp sequence of "exon-X" is not portrayed. This updated N-terminal rat kinin B 2 receptor sequence is presently used as a reference for the rat gene (Martins et al., 2008; Sivritas et al., 2008; Hansen et al., 2009; Tang et al., 2009 ). We also now have a better understanding of the mouse and human kinin B 2 receptor genes. As in the rat, the mouse and human ORFs consist of a continuous 1.1-kb sequence, all contained in 5'exon-3 ( Figure 5 ). In contrast, earlier models of the mouse and human gene structures predicted from mRNA (Ma et al., 1994b; Hess et al., 1992) showed 0.7 kb of 3'ORF regions of mouse and human exon, 2 with the reminder of the ORF region in exon-3. Investigation of the murine and human genomes permitted identification of the mistake in gene structure prediction; consequently, the concept of the kinin B 2 receptor or gene-encoding region being in one intronless exon is also sustained for the mouse and human genes.
When we examine rat kinin B 2 receptor gene product processing, it is not yet clear whether the observed fragment removal pattern is common to the processing of other receptorprotein gene products of the same family. The fact that the "exon-X" nucleotide sequence was not found in polyadenylated mature mRNA in a wide range of tissues pertaining from various rat strains, both in unstimulated tissues or during an acute inflammatory process, which promotes expression of B 1 kinin receptor mRNA, practically rules out the possibility of alternative processing of the B 2 receptor gene that would lead to expression of an "exon-X"-containing mature gene product in adult animals. Furthermore, the lack of evidence for sustained expression of kinin B 2 receptor encoding gene products during early and late embryonic development is further evidence that the "exon-X"-containing gene product is not a constitutively or inductively expressed gene sequence in the mature or developing rat.
During the initial cloning of the rat kinin B 2 receptor gene by McEachern et al. (1991) , the "exon-X" gene was included as part of the gene-encoding sequence. This lead to a hypothesis of alternative processing of the B 2 receptor protein gene. According to this hypothesis, alternative gene splicing would produce two mature mRNAs, one of them containing the 211-bp sequence of "exon-X", the earlier initially dubbed "exon-3" (Pesquero et al., 1994) . The latter configuration suggested a four-exon, three-intron gene structure for the rat gene. Others (AbdAlla et al., 1996) , based on in vitro studies, reported that the "exon-X" transcripts, containing an AUG initiation codon anteceding an ORF in the purported "exon-X", would add about 27 amino acids to the N-terminal end of the human and rat kinin receptor proteins. The reasons for "exon-X" to be mistakenly identified as a constituent of the mature B 2 kinin receptor mRNA (Pesquero et al., 1994) are hinged on two non-converging aspects apart from the misleading published information (McEachern et al., 1991) . First, the methodology used to isolate the poly-adenylated mRNA (poly-T columns) was not sufficiently stringent and thus permitted substantial amplification of primary mRNA transcripts containing "exon-X" genetic material. Second, the late removal of "exon-X", after that of intron-3, generating an apparent four-exon amplification product (albeit unsuspectingly amplified from primary mRNA), resulting in a false perception of an anticipated four-exon, three-intron gene structure. Here, we amplified mature mRNA from reverse transcripts using poly-T primers as transcription initiators. The stringency of this approach is attested by the fact that fragments containing intron sequences were never amplified from polyadenylated mRNA preparations.
However, these findings clearly demonstrate a functional three-exon gene structure for the rat kinin B 2 receptor gene, notwithstanding the purported in vitro expression of translated "exon-X" ORF N-terminal residues. In fact, the transcribed sequence that putatively encodes the rat "exon-X" ORF is not identifiable in the mammalian, avian, amphibian nor teleost fish genes encoding the kinin B 2 receptor proteins. The fact that mature mRNA containing the "exon-X" sequence was not detected in embryonic rat mRNA may not be relevant to this hypothesis, since it could be expressed in minute amounts, in specific tissues and during a very short time period, possibly hours or less, as may be the case for the ETB endothelin receptor gene during ontogenetic development of the gut (Suzuki et al., 2004) . Neither does this mean that the potentially extended kinin B 2 receptor protein would necessarily be devoid of function if were expressed during early development. The lack of expression of the ETB receptor in the gut during a short period of organogenesis leads to a condition analogous to that of muscularis inflammation and the loss of Cajal interstitial cells, leading to intestinal obstruction and premature death of sub-adult endothelin-ETB receptor cells (Suzuki et al., 2004) . The expression of the kinin B 2 receptor encoding mRNA sharply increases in proportion to that of β-actin protein during early organogenesis and levels off during fetal growth, demonstrating the significance of this kinin B 2 receptor for the multiple physiological functions played by kinins in the mature organism.
"Exon-X"-containing mature mRNA was not found in a wide range of tissues of adult Wistar, Sprague-Dawley and SHR animals, including brain structures known to express high densities of kinin receptors, such as the nucleus of the solitary tract, the paratrigeminal nucleus. Neither was the "exon-X"-containing mature mRNA found in the hypothalamus, which expresses components of the kinin-kallikrein system (Couture and Lindsey, 2000) . The visceral tissues that were examined included those of arteries, lungs, kidneys, liver, stomach, ovaries, and uterus; the latter tissue was used for molecular cloning of the B 2 kinin receptor gene.
Thus, the structure of the rat gene may be considered akin to that of the mouse and human kinin B 2 receptor genes; all include a three-exon structure, as depicted in Figure 5 . The latter displays the three-exon gene structure of the kinin B 2 receptor gene, based on our interpretation here and the finding of a single mature mRNA product. The lack of success in finding homology of the predicted ~30 residue N-terminal of the human or rat kinin receptor (AbdAlla et al., 1996) with the predicted kinin proteins of the frog (Suzuki et al., 2007) , zebra and puffer fish (Bromée et al., 2005 (Bromée et al., , 2006 , as well as avian and mammal proteins, suggest that the "exon-X"-encoded protein N-terminus is not expressed in these animal classes. However, the 211-bp sequence of exon-X still has significant homology with the mouse intron region between exons 2 and 3. Comparing rat and mouse exons 1, 2 and "X" gives interspe-cies homology ratings of 84, 83 and 76%, respectively; it appears that the latter gene fragment is under lower conservational pressure (Kumar and Hedges, 1998; Blair Hedges and Kumar, 2003) than exons 1 and 2. The same holds true when compared to the 1.3-kb sequence of the rat 2.6-kb 3' UTR. Half of the 1.3-kb sequence aligned with position 33248-34000 and the other half with position 34988-35801 of the mouse kinin B 2 receptor gene. The homology of these alignments was 84 and 80%, respectively, suggesting that the 3' UTR of the gene are under greater selective pressure (Blair Hedges and Kumar, 2003) than exon-X. Curiously, 18 bases of the 211-bp sequence showed 90% homology with the human 3' UTR at position 47101-47120. The significance, if any, of the latter sequence homology, which covers only 8.5% of "exon-X", is not clear.
Further investigation will be required to understand the evolutionary implications of "exon-X". It is possible that this fragment is the result of an early interstitial gene duplication (Prowald et al., 2005) , resulting in the 211-bp insertion, with subsequent loss of the duplicate sequence. "Exon-X" could also be an ancestral form of the gene. Considering that "exon-X" is removed late during processing after the downstream intron-3 and that it has an AUG initiation codon that in in vitro systems prevails over the in vivo functional exon-3 translation-initiation codon, it is possible that the current gene structure reflects earlier forms of this protein, probably expressed in phylogenic ancestrals of amphibians and teleosts. However, a more compelling hypothesis for the origin of this 211-bp fragment is that it arose from a homologous, orthologous or heterologous transposon inserted before the 3' flanking regions of kinin B 2 receptor intron-2. This exon-like fragment, containing an AUG close to its 5' extremity, would create an impression of a four-exon, three-intron gene structure. Transposable elements (Nekrutenco and Li, 2001 ) together with polyploidy duplication (Beçak and Kobashi, 2004) are one of the main mechanisms for promotion of diversity and genetic material gain in vertebrates. Approximately 90% of the transposons in a phylogenetically recent and rapidly evolving species, such as Homo sapiens, were inserted into introns (Nekrutenco and Li, 2001 ) and were recruited into encoding regions as novel exons.
